Nothing Special   »   [go: up one dir, main page]

EA202190858A1 - SAFE AND EFFECTIVE METHOD FOR TREATMENT OF ULCER WITH ANTIBODIES TO IL-12 / IL-23 - Google Patents

SAFE AND EFFECTIVE METHOD FOR TREATMENT OF ULCER WITH ANTIBODIES TO IL-12 / IL-23

Info

Publication number
EA202190858A1
EA202190858A1 EA202190858A EA202190858A EA202190858A1 EA 202190858 A1 EA202190858 A1 EA 202190858A1 EA 202190858 A EA202190858 A EA 202190858A EA 202190858 A EA202190858 A EA 202190858A EA 202190858 A1 EA202190858 A1 EA 202190858A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antibodies
safe
treatment
ulcer
effective method
Prior art date
Application number
EA202190858A
Other languages
Russian (ru)
Inventor
Джуэл Джоаннз
Кэтрин Ли
Коллин Марано
Ричард Штраусс
Хунянь Чжан
Омонийи Абедокун
Кристофер О'Брайен
Кимберли Шилдз-Таттл
Original Assignee
Янссен Байотек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Байотек, Инк. filed Critical Янссен Байотек, Инк.
Priority claimed from PCT/IB2019/058098 external-priority patent/WO2020065532A1/en
Publication of EA202190858A1 publication Critical patent/EA202190858A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Описаны способы и композиции для клинически подтвержденного безопасного и эффективного лечения язвенного колита, в частности язвенного колита умеренной или выраженной активности, у пациентов с неадекватным ответом или непереносимостью стандартной или существующей терапии путем внутривенного и/или подкожного введения антитела к IL-12/IL-23p40.Described are methods and compositions for clinically proven safe and effective treatment of ulcerative colitis, in particular ulcerative colitis of moderate to severe activity, in patients with an inadequate response or intolerance to standard or existing therapy by intravenous and / or subcutaneous administration of antibodies to IL-12 / IL-23p40 ...

EA202190858A 2019-09-04 2019-09-24 SAFE AND EFFECTIVE METHOD FOR TREATMENT OF ULCER WITH ANTIBODIES TO IL-12 / IL-23 EA202190858A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962895774P 2019-09-04 2019-09-04
PCT/IB2019/058098 WO2020065532A1 (en) 2018-09-24 2019-09-24 Safe and effective method of treating ulcerative colitis with anti-il12/il23 antibody

Publications (1)

Publication Number Publication Date
EA202190858A1 true EA202190858A1 (en) 2021-06-23

Family

ID=76807392

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202190858A EA202190858A1 (en) 2019-09-04 2019-09-24 SAFE AND EFFECTIVE METHOD FOR TREATMENT OF ULCER WITH ANTIBODIES TO IL-12 / IL-23

Country Status (1)

Country Link
EA (1) EA202190858A1 (en)

Similar Documents

Publication Publication Date Title
EA202090595A1 (en) ENPP1 INHIBITORS AND IMMUNE RESPONSE MODULATION METHODS
MX2023012450A (en) Esketamine for the treatment of depression.
MX2021003411A (en) Safe and effective method of treating ulcerative colitis with anti-il12/il23 antibody.
EA201891606A1 (en) COMPOSITIONS AND METHODS FOR INTRAVENOUS INTRODUCTION OF 2-BROM-1- (3,3-DINITROAZETIDIN-1-IL) ETHANON
MX2021001762A (en) Method and composition for stimulating immune response.
EA201792547A1 (en) BACTERIA POPULATIONS FOR STIMULATING HEALTH CONDITION
MX2021000898A (en) METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH).
MX2021000289A (en) Methods for treating high cardiovascular risk patients with hypercholesterolemia.
MX2020001768A (en) Methods of treatment of osteoarthritis with transdermal cannabidiol gel.
WO2019067405A3 (en) Ketogenic diet compatible fenfluramine formulation
EA201690680A1 (en) COMBINED ANTI-TUMOR TREATMENT WITH THE APPLICATION OF MINICOLES, LOADED BY MEDICINE MEANS, AIMED USING THE BISPECIFIC LIGAND, AND INTERFERON-GAMMA
EA202190197A1 (en) TREATMENT OF ULCER WITH BRAZIKUMAB
EA202190858A1 (en) SAFE AND EFFECTIVE METHOD FOR TREATMENT OF ULCER WITH ANTIBODIES TO IL-12 / IL-23
WO2018062876A3 (en) Kit for treatment of osteoarthritis to reduce pain
WO2017181099A8 (en) Dosage and administration of anti-igf-1r, anti-erbb3 bispecific antibodies, uses thereof and methods of treatment therewith
MX2020007222A (en) Minocycline for treating inflammatory skin conditions.
MX2023005014A (en) Methods of treating chronic inflammatory diseases.
EA202192459A1 (en) METHOD FOR TREATMENT OF PSORIASIS WITH ANTIBODY TO IL12 / IL23 IN CHILDREN
MX2021004463A (en) Arginine depletion therapy for treatment of gamt deficiency.
RU2012151726A (en) METHOD OF STIMULATION OF HEALING OF RAS OF VARIOUS GENESIS BY NATURAL ANTIOXIDANT DIHYDROQUERCERETINE
WO2019241742A8 (en) Combination of ezh2 inhibitor and checkpoint therapy for the treatment of cancer
EP4233842A3 (en) Avexitide for the treatment of hyperinsulinemic hypoglycemia
EA201690903A1 (en) TREATMENT GLAUCOMA USING LAQUINIMODE
MX2021001502A (en) Treatment of warts.
EA202190294A1 (en) COMBINATION THERAPY FOR CANCER TREATMENT